FilingReader Intelligence

Fosun Pharma cuts private equity fund commitment by 7.6bn yuan

July 16, 2025 at 05:12 AM UTCBy FilingReader AI

Fosun Pharma's board approved a 7.6 billion yuan reduction in its Suzhou Angel Fund commitment, decreasing the total fund size to 10 billion yuan.

The adjustment, effective July 15, 2025, maintains Fosun Pharma's 62.50% stake in the fund.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600196Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →